WednesdayJul 18, 2018 9:00 am

Hemp CBD Products Offer a Natural Alternative to Synthetic-Derived Medicines

CBDWire Editorial Coverage: The opioid crisis in North America has drawn attention to the urgent need for alternative medicines, and hemp CBD products offer a viable plant-based option. An active ingredient in industrial hemp, Cannabidiol (CBD) can be extracted to be used in a number of different products such as topicals, tinctures, and capsules. The World Health Organization (WHO) has found CBD to be nonpsychoactive, nonaddictive, and to have a positive effect on patients’ health. Scientific studies have shown CBD to be effective in pain relief and, therefore, it may be a healthier alternative to addictive opioids. Marijuana Company of…

Continue Reading

TuesdayJul 10, 2018 9:00 am

Cannabidiol Market Anticipates Growth as Regulatory Change Looms in U.S.

CBDWire Editorial Coverage: Restrictions in the United States on cannabidiol (CBD), an active ingredient in cannabis, appear likely to loosen over the next few months, creating opportunities for CBD production and distribution companies. CBD is an active ingredient with medical benefits but no “high”, or pyshcoactive effects. The Food and Drug Administration (FDA) has approved a CBD-based medicine for the first time. Companies are cultivating hemp to develop high yielding CBD plants. Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile) is cultivating industrial hemp for CBD  propagation at sites in the United States and Canada while continuting to develop…

Continue Reading

WednesdayJun 27, 2018 9:00 am

Farm Bill Legislation May Springboard Federal Hemp Acceptance

CBDWire Editorial Coverage: The United States House passed the 2018 Farm Bill, which will redefine subsidies to farmers, nutritional welfare recipients, conservationists and others. Tucked into this bill of more than 1,000 pages is hemp legalization legislation supported by Senate Majority Leader Mitch McConnell. Demand – and thus farming revenue – for tobacco is waning, and McConnell says hemp farming could help bolster farming communities in his home state of Kentucky and across the country. Currently listed as a controlled substance under federal law, the new bill will declassify hemp as a schedule 1 drug and label it as a…

Continue Reading

WednesdayJun 20, 2018 9:00 am

Dangers Lurking in Synthetic CBD Underscore Value of Quality Product

CBDWire Editorial Coverage: Dating back thousands of years, people have found ways to treat pain and other ailments with cannabidiol (CBD) oil which is harvested from the hemp plant. However, the natural healing properties of CBD are being jeopardized by the advent of man-made synthetic CBDs. These chemical analogs are dangerous imitations of plant-derived product, binding to human endocannabinoid receptors at astronomically larger quantities than natural cannabinoids. These designer drugs prompted the U.S. Centers for Disease Control and Prevention to issue a national health alert warning about synthetic cannabinoids. Shunning synthetics, Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile)…

Continue Reading

WednesdayJun 13, 2018 9:00 am

Government Interest in Hemp Diversity Signals Strong Future for American Cannabis Industry

CBDWire Editorial Coverage: Recent U.S. government interest in ensuring industrial hemp supply signals a period of growth for the cannabinoid industry. Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile) is contributing to this growth through new hemp cultivation projects in both Canada and the U.S., to support its hempSMART subsidiary. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) is benefiting from a cross-border venture that gives it access to new scientific advances and has seen its shares reach top exchanges. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) has secured government licensing needed to become one of Canada’s leading retailers, while…

Continue Reading

ThursdayJun 07, 2018 9:00 am

Diversity Leads to Growth in Flourishing Cannabinoid Industries

CBDWire Editorial Coverage: The cannabis industry is about more than medicine and recreational drugs. Whether selling hemp-derived textile and construction products or providing resources to support cannabis growers, companies are now accessing the market in a variety of ways. Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile) is developing hemp-based wellness products and cultivating industrial hemp on a large scale in Canada and the United States. Scotts Miracle-Gro Company (NYSE: SMG) is selling hydroponic equipment to legal cannabis growers and has recently made a significant acquisition in this area. Cronos Group, Inc. (TSX: CRON) (NASDAQ: CRON) has used its…

Continue Reading

ThursdayMay 31, 2018 9:00 am

CBD Market Set for Huge Growth

CBDWire Editorial Coverage: In a fragile economic world, industries with significant growth forecast are certain to catch the eye of savvy investors looking for just the right place to be. Recent reports indicate that the cannabidiol (CBD) market is estimated to grow by 700 percent by 2020, and a report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020 (http://cnw.fm/7iczS), an astronomical jump in value compared to last year’s CBD market of $202 million. This news bodes well for hemp-focused companies such as Marijuana Company of America (OTC: MCOA) (MCOA…

Continue Reading

ThursdayMay 24, 2018 9:00 am

CBD Solid Bedrock as US Heads Back to Industrial Hemp Roots

CBDWire Editorial Coverage: With the announcement in April of the Industrial Hemp Farming Act of 2018, the industry could be looking at a federal redefinition of hemp. Industrial hemp is a great source for CBD (cannabidiol), a non-psychoactive cannabinoid with numerous medical applications ranging (http://cnw.fm/7tqIy). U.S. market projections for hemp range from $1.9 to $2.1 billion within the next two years and could hit $3 billion by 2021, according to one industry analyst (http://cnw.fm/MLA5w). This is great news for well-positioned sector players such as Marijuana Company of America (OTC: MCOA) (MCOA Profile), which recently executed a sizeable hemp-cultivation JV agreement.…

Continue Reading

WednesdayMay 23, 2018 9:00 am

Opportunities for Growth Found in Burgeoning Cannabis Industry

CBDWire Editorial Coverage: The legalization of cannabis for recreational use in Canada appears to be certain by the end of summer. The legislation to begin that process was passed by the government in late 2017 and passed a second reading in the country’s Senate in March 2018; the final vote is scheduled for June of this year, and the passage appears all but certain. Approval of the law — along with the fact that recreational cannabis is already legal in nine U.S. states — will spark an industry that forecasts indicate may reach as high as $12B in North America…

Continue Reading

WednesdayMay 02, 2018 9:00 am

Subsidiary Industries Prepare for Growing Cannabis Market

CBDWire Editorial Coverage: Impending legislation in Canada is the most recent step in the spread of legal cannabis consumption. As the industry grows, so do the support businesses supplying related services for retailers and consumers. Global Payout, Inc. (GOHE) (GOHE profile) is providing payment systems and business support through its MoneyTrac partnership. MassRoots Retail (OTC: MSRT) is using blockchain to provide a review aggregator and dispensary finder. GB Sciences, Inc. (OTCQB: GBLX) is working in research and design, focusing its efforts on growing more effective strains and exploring better delivery systems. Lexaria Bioscience Corporation (CSE: LXX) (OTCQX: LXRP) is also…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000